Product Information

PIOGLITAZONE-METFORMIN 15-500 is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3220 per EA under NDC 65862052518. Its NADAC has been published 637 times since Jun 11, 2014.

FDA first approved this application on Feb 13, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PIOGLITAZONE-METFORMIN 15-500

Pioglitazone Hydrochloride and Metformin Hydrochloride
$0.3220per EA

Strength

500; 15 mg/1; mg/1

NDC

65862052518

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA200823

FDA Approved

2/13/2013

TE Code

AB

On Market Since

2/13/2013

Pharmacological Classes

Biguanide
Biguanides
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE-METFORMIN 15-500 has been published 637 times since Jun 11, 2014, and over the history we have for it it has declined 85.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3220 per EA
All-time high$2.2829 (Jul 16, 2014)
All-time low$0.1994 (Apr 19, 2023)
52-week high$0.5670
52-week low$0.3220
Median price$0.7361
Average price$0.9101
Largest weekly change+79.1% (Apr 17, 2024)
Weeks tracked637
Tracking sinceJun 11, 2014

Price History

1W

-14.5%

1M

-14.5%

3M

-21.5%

6M

-14.5%

1Y

-43.2%

3Y

-17.9%

5Y

-49.1%

All

-85.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE-METFORMIN 15-500?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-METFORMIN 15-500, manufactured by Aurobindo Pharma Limited, is $0.3220 per EA (NDC 65862052518), effective Aug 19, 2026.

How has the price of PIOGLITAZONE-METFORMIN 15-500 changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE-METFORMIN 15-500 has declined 85.1%. It has been tracked across 637 weekly CMS publications since Jun 11, 2014.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-METFORMIN 15-500?

Since Jun 11, 2014, the NADAC for PIOGLITAZONE-METFORMIN 15-500 has ranged from a low of $0.1994 (Apr 19, 2023) to a high of $2.2829 (Jul 16, 2014), with a median of $0.7361 per EA.

Are there cheaper alternatives to PIOGLITAZONE-METFORMIN 15-500?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE-METFORMIN 15-500 in a comparable dosage form, but none are currently priced below it.

Who manufactures PIOGLITAZONE-METFORMIN 15-500?

PIOGLITAZONE-METFORMIN 15-500 (NDC 65862052518) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.